CPT® Code 81302

The CPT® Code 81302 refers to the full sequence analysis of the MECP2 (methyl CpG binding protein 2) gene, which is crucial for diagnosing conditions such as Rett syndrome. This molecular genetic testing aims to identify specific mutations within the MECP2 gene, which encodes a protein essential for normal nerve cell functioning. The MECP2 protein plays a significant role in the brain, acting as both a transcriptional repressor and activator, and is found in high concentrations in neurons, where it is vital for forming synapses—connections that facilitate communication between nerve cells. The MECP2 gene is located on the X chromosome and is primarily associated with paternal-linked autosomal dominant mutations. Mutations in the MECP2 gene are implicated in most cases of Rett syndrome, a progressive neurological and developmental disorder that predominantly affects females. Typically, individuals with classic Rett syndrome exhibit normal growth and development for the first 6 to 18 months of life, after which they begin to experience severe challenges in language, communication, learning, coordination, and overall brain function. There are atypical forms of the syndrome as well, including a mild variant where speech is preserved and a severe variant that lacks any period of normal development. Research indicates that approximately 90% of classic Rett syndrome cases arise from new ('de novo') mutations, with no prior family history of the disorder. While males with the MECP2 mutation often do not survive past infancy, a small number of males with classic Rett syndrome have been identified, typically possessing an extra X chromosome that allows for the production of sufficient MECP2 protein for survival. The full sequence analysis performed under CPT® Code 81302 involves comparing gene segments to identify similarities, differences, and relationships, as well as studying intrinsic features to locate active sites and gene structures. This analysis can reveal genetic markers by identifying point mutations or single nucleotide polymorphisms (SNPs). Various types of mutations, including point mutations and insertion/deletion mutations, have been documented in individuals diagnosed with Rett syndrome. Additionally, MECP2 mutations have been associated with moderate to severe X-linked mental retardation (XLMR), neonatal encephalopathy, and certain autism cases, highlighting the gene's significance in a range of neurological conditions.